Surgery for aortic graft infection is a major challenge often characterized by the need for ingenuity and improvisation. Traditional treatment is by total graft excision and extra-anatomic bypass. In situ replacement of the infected graft using either autogenous tissue or antibiotic-impregnated Dacron is effective in selected cases but it is not clear when such conservative treatment may be employed. Graft excision and thorough débridement of infected tissue are important, whichever technique is used. It would seem unwise to perform in situ reconstruction unless the remaining operative field is free from contamination. When in situ replacement is selected, a rifampicin-soaked Dacron graft is the easy option, but large studies will be needed to determine whether this is a suitable long-term alternative to conventional treatment.
StrachanCJLNewsomSWBAshtonTR. The clinical use of antibiotic bonded graft. Eur J Vasc Surg1991; 5: 627–32.
2.
CalligaroKDVeithFJ. Diagnosis and management of infected prosthetic aortic grafts. Surgery1991; 110: 805–13.
3.
BandykDFEssesGE. Prosthetic graft infection. Surg Clin N Am1994; 74: 571–90.
4.
YeagerRAMonetaGLTaylorLMMcConnellDBPorterJM. Can prosthetic graft infection be avoided? If not, how do we treat it?Acta Chir Scand1990; Suppl. 555: 155–63.
5.
EdminstonCESchmittDDSeabrookGR. Coagulase-negative staphylococcal infections in vascular surgery: Epidemiology and pathogenesis. Infect Control Hosp Epidemiol1989; 10: 111–17.
6.
VinardEEloyRDescotesJHuman vascular graft failure and frequency of infection. J Biomed Mater Res1991; 25: 499–513.
7.
FioraniPSpezialeFRizzoL.Detection of aortic graft infection with leucocytes labelled with Technetium 99m-Hexametazime. J Vasc Surg1993; 17: 87–96.
HakaimEGHertzerNRO'HaraPJKrajewskiLPBevenEG. Autogenous vein grafts for femorofemoral revascularisation in contaminated or infected fields. J Vasc Surg1994; 19: 912–15.
10.
KretschmerGNiederleBHukIGroin infections following vascular surgery: Obturator bypass versus “biologic coverage” — A comparative analysis. Eur J Vasc Surg1989; 3: 25–9.
11.
McCannRLSchwartzLBGeorgiadeGS. Management of abdominal aortic graft complications. Ann Surg1993; 217: 729–34.
12.
SharpWJHoballahJJMohanCRThe management of the infected aortic prosthesis: A Current decade of experience. J Vasc Surg1994; 19: 844–50.
13.
QvarfordtPGReillyLMEhrenfieldWKStoneyRJ. Surgical management of vascular graft infections — Local treatment, graft excision and methods of revascularization. In: BernhardVMTowneJB eds. Complications in Vascular Surgery.Vol. 31. London: Grune and Stratton, 1985: 499–511.
14.
LehnertTGruberH-PMaederNAllenbergJ-R.Management of primary aortic graft infection by extra-anatomic bypass reconstruction. Eur J Vasc Surg1993; 7: 301–7.
15.
SantiniCBaiocchiPVendittiMAorto-femoral graft infections: A clinical and microbiological analysis. J Infect1993; 27: 17–26.
16.
MorrisGEFriendPJVassalloDJFarringtonMLeapmanSQuickCRG. Antibiotic irrigation and conservative surgery for major aortic graft infection. J Vasc Surg1994; 20: 88–95.
17.
GordonAConlonCCollinJAn eight year experience of conservative management for aortic graft sepsis. Eur J Vasc Surg1994; 8: 611–16.
18.
KiefferEBahniniAKoskasFRuotoloCLe BlevecDPlissonnierD.In situ allograft replacement of infected infrarenal aortic prosthetic grafts: Results in forty-three patients. J Vasc Surg1993; 17: 349–56.
19.
NevelsteenALacroixHSuyR.Autogenous reconstruction with the lower extremity deep veins: An alternative treatment of infection after surgery for aortoiliac disease. J Vasc Surg1995; 22: 129–34.
20.
BadylakSFCoffeyACLantzGCTackerWAGeddesLA. Comparison of the resistance to infection of intestinal submucosa arterial autografts versus polytetrafluoroethylene arterial prostheses in a dog model. J Vasc Surg1994; 19: 465–72.
21.
RobinsonAAJohansenK.Aortic sepsis: Is there a role for in situ graft reconstruction?J Vasc Surg1991; 13: 677–84.
22.
MillerJH. Partial replacement of an infected arterial graft by a new prosthetic polytetrafluoroethylene segment: A new therapeutic option. J Vasc Surg1993; 17: 546–8.
23.
StrachanCJL. Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery. J Antimicrob Chemother1993; 31(Suppl. B): 65–78.
24.
ToreslloGSandmannWGehrtAJungblutRM. In situ replacement of infected vascular prostheses with rifampicin-soaked vascular grafts: Early results. J Vasc Surg1993; 17: 768–73.
25.
NaylorARClarkSLondonNJMTreatment of aortic graft infection: Preliminary experience with total graft excision and in situ replacement with a rifampicin bonded prosthesis. Eur J Vasc Endovasc Surg1995; 9: 252–6.
26.
NielsenOMNoerHHJorgensenLGLorentzenJE. Gentamycin beads in the treatment of localised vascular graft infection — Long term results in 17 cases. Eur J Vasc Surg1991; 5: 283–5.
27.
JorgensenLGSorensenTSLorentzenJE. Clinical and pharmacokinetic evaluation of gentamycin containing collagen in groin wound infections after vascular reconstruction. Eur J Vasc Surg1991; 5: 87–91.
28.
Goeau-BrissoniereOAKoskasFPechereJ-C.Prevention of early wound and graft infection with rifampicin-bonded knitted polyester grafts: A prospective randomized study. J Vasc Surg1995 (in press).
29.
FichelleJETabetGCormierPInfected infrarenal aortic aneurysms: When is in situ reconstruction safe?J Vasc Surg1993; 17: 635–45.
30.
TowneJBSeabrookGRBandykDFreischlagJAEdminstonCE. In situ replacement of arterial prosthesis infected by bacterial biofilms: Long-term follow-up. J Vasc Surg1994; 19: 226–35.
31.
JacobsMjhmReulGJGregoricICooleyDA. In situ replacement and extra-anatomic bypass for the treatment of infected abdominal aortic grafts. Eur J Vasc Surg1991; 5: 83–6.
